[通过高频听力测定法验证接受透析患者去铁胺的耳毒性]
[Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis].
作者信息
Martín C, Lens X M, Prieto A, Alonso R, Correa B, Arcocha V, Soto A
机构信息
Hospital General De Galicia, Facultad de Medicina, Universidad de Santiago, Santiago de Compostela.
出版信息
An Otorrinolaringol Ibero Am. 1994;21(2):193-8.
PMID:8209972
Abstract
The AA. have studied the Desferrioxamine ototoxicity with high frequency audiometry (HFA), given the drug as a test for diagnosis of aluminium-related done disease in patients under dialysis. The dose of 10 mg/kg presents high sensitivity and low ototoxicity.
摘要
研究人员采用高频听力测定法（HFA）对去铁胺的耳毒性进行了研究，将该药物用于透析患者铝相关性骨病的诊断测试。10毫克/千克的剂量具有高敏感性和低耳毒性。
Zotero 插件